Abstract:Abstract Objective: To analyze the impact of thyroid autoimmunity (TAI) on reproductive outcome parameters of ICSI cycles as compared to TAI negative ICSI cycles. Design: In this single IVF center retrospective study 86 infertile women with elevated TPOAb or TGAb levels, but euthyroid after thyroxine replacement (study group), were compared to 69 female patients with no thyroid abnormalities (controls). Following ICSI treatment fertilization rate (FR), clinical pregnancy rate (CPR), miscarriage rate (MR) and live birth rate (LBR) were analyzed. Materials, Setting, Methods: All subjects with various infertility factors were treated with ICSI in university based IVF center. Patients in the study group received thryroxine replacement and were euthyreoid at IVF treatment. Before the IVF cycles endocrinological parameters were uniformly assessed: thyroid function and antibodies, reproductive hormones (AMH, FSH, LH, E2, PRL, testosterone, DHEAS, 17-OHP, AD) and OGTT (0-60-120 min glucose and insulin). Following descriptive comparison of laboratory parameters, age adjusted analyses of FR, CPR, MR and LBR were performed. Results: TAI positive women were older (mean age 35.31±4.95 vs. 32.15±4.87 years; p=0.002), had higher FSH (8.4±3.4 vs. 7.4±2.32 U/L; p=0.024), higher E2 (53.94±47.61 vs. 42.93±18.92 pg/ml; p=0.025) levels, while AMH (2.88±2.62 vs. 3.61±1.69 ng/ml; p=0.0002) was lower. There were no differences in TSH levels (1.64±0.96 vs. 1.66±0.65 uIU/ml; p=0.652) between the two groups. FT3 (2.63±0.58 vs. 2.98±0.55 pg/ml; p=0.002) was lower and FT4 (1.3±0.29 vs. 1.13±0.21 ng/dl; p=0.0002) was higher in the TAI positive group, reflecting clinically irrevelant differences. Egg cell counts (6±3.8 vs. 7.5±3.95; p=0.015) were lower in TAI and remained so following age adjustment. Although the overall ICSI FR did not differ (62.9 % vs. 69.1 %, p=0.12), it was lower for patients under 35 with TAI showing decreasing differences in line with age. The CPR (36.04 % vs. 69.56 %; p<0.001), LBR (23.25 % vs. 60.86 %; p<0.001) were lower, the MR (35.48 % vs. 12.5 %; p=0.024) was higher in the TAI group and these differences remained after age adjustment. Limitations: Since the higher age of the study group may interfere with the effect of TAI, age adjustment calculations were necessary to perform to eliminate this confounding factor. Conclusion: Despite optimal thyroid supplementation in clinical or subclinical hypothyreoidism, the presence of TAI negatively influences clinical pregnancy rate and is connected to a higher miscarriage rate, thus resulting in a lower live birth rate after ICSI. Decreased fertilization rate with ICSI in TAI patients may also contribute to poorer outcomes, especially in younger women.

Impact of Thyroid Cancer Treatment on Assisted Reproductive Technology Outcomes in Women with Infertility

IVF/ICSI Outcomes of Euthyroid Infertile Women with Thyroid Autoimmunity: Does Treatment with Aspirin Plus Prednisone Matter?

Analysis of in vitro fertilization/intracytoplasmic sperm injection outcomes in infertile women with a history of thyroid cancer: a retrospective study

Effect of Antithyroid Antibodies in the First Trimester on Pregnancy Outcomes

Impact of Thyroid Autoimmunity on in Vitro Fertilization/Intracytoplasmic Sperm Injection Outcomes and Fetal Weight.

Effect Of Antithyroid Antibodies On Women With Recurrent Miscarriage: A Meta-Analysis

Effect of Antithyroid Antibodies on Women with Recurrent Miscarriage: A Meta‐analysis

Impact of thyroid autoimmunity on pregnancy outcomes in euthyroid patients with recurrent implantation failure.

Influence Of Hypothyroidism On In Vitro Fertilization Outcomes

Intracytoplasmic Sperm Injection Versus in Vitro Fertilization in Infertile Women with Thyroid Autoimmunity.

Pregnancy Outcomes in Thyroid Cancer Survivors: A Propensity Score-Matched Cohort Study

Hashimoto’s thyroiditis negatively influences ICSI outcome in euthyroid women on T4 substitution therapy; a retrospective study

Basic thyroid function and pregnancy outcome in IVF-ET

Relationship Between Antithyroid Antibody And Pregnancy Outcome Following In Vitro Fertilization And Embryo Transfer

The effect of thyroid autoantibody on assisted reproduction technology outcome in euthyroid women: One center experience

Impact of thyroid autoimmunity and vitamin D on in vitro fertilization/intracytoplasmic sperm injection outcomes among women with normal thyroid function

TPOAb positivity can impact ovarian reserve, embryo quality, and IVF/ICSI outcomes in euthyroid infertile women

The impact of thyroid autoimmunity on pregnancy outcomes in women with unexplained infertility undergoing intrauterine insemination: a retrospective single-center cohort study and meta-analysis

Preconceptional Thyroid-Stimulating Hormone Affects Antral Follicle Count Rather Than Pregnancy Outcomes in Patients with First in Vitro Fertilization/intracytoplasmic Sperm Injection Cycle

Thyroid function and IVF outcome for different indications of subfertility

SAT-LB097 the Effect of 131I Treatment on Pregnancy Outcomes after Thyroidectomy in Patients with Differentiated Thyroid Carcinoma: A Meta-Analysis